The Psychosocial Burden of HCV Infection and the Impact of Antiviral Therapy on the Quality of Life in Liver and Kidney Transplant Recipients: A Pilot Study

<div>STAI 1, STAI 2, and Zung mean scores at baseline, 12 (T12), and 24 (T24) weeks after the end of DAA therapy in LT and KT patients. Legend: LT: liver transplant; KT: kidney transplant.</div>

Gastroenterology Research and Practice

fig1

Figure 1

Figure 1: The Psychosocial Burden of HCV Infection and the Impact of Antiviral Therapy on the Quality of Life in Liver and Kidney Transplant Recipients: A Pilot Study 

Figure 1 | The Psychosocial Burden of HCV Infection and the Impact of Antiviral Therapy on the Quality of Life in Liver and Kidney Transplant Recipients: A Pilot Study 